Comparative Study Between Liberal and Conservative Oxygen Therapy in Mechanically Ventilated Intensive Care Patients

Sponsor
Aswan University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04824703
Collaborator
(none)
100
1
2
19.9
5

Study Details

Study Description

Brief Summary

To assess the benefits and drawbacks of high versus low oxygen therapy on mortality and myocardial function in mechanically ventilated patients

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparative Study Between Liberal and Conservative Oxygen Therapy in Mechanically Ventilated Intensive Care Patients
Actual Study Start Date :
Apr 5, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conservative oxygen therapy

Spo2 alarm limit will be set as follow: - upper limit 94% and lower limit 88% If spo2 >94% Unless fio2 is 0.21%, decrease fio2 by 0.10% at intervals no longer than 5 minutes till spo2 = 94% If spo2 within target Decrease fio2 0.05% at intervals no longer than 30 min till fio2 0.21% reached or spo2 = 88 % If spo2 < 88 % return to previous spo2 that achieve target spo2. if an arterial blood gas demonstrate that the PaO2 is < 60 mmHg FiO2 will increased if clinically appropriate irrespective of the SpO2 reading ( target po2 60-100 mmhg ) During intubation, airway suction, tracheostomy, bronchoscopy, transportation outside of the ICU for radiological or other investigations or for procedures or operations, other critical situations such as hemodynamic collapse, patients will receive standard (non-study)treatment. Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view

Drug: Oxygen
Decreasing fraction of inspired oxygen and its effect on mortality and myocardial function administered by invasive mechanical ventilation with fraction of inspired oxygen between 0.21 and 1

Placebo Comparator: Liberal oxygen therapy

Spo2 target > 95% No specific measures will be taken to avoid high fio2 or high po2 Use of upper alarm limit for spo2 will be prohibited Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view

Drug: Oxygen
Decreasing fraction of inspired oxygen and its effect on mortality and myocardial function administered by invasive mechanical ventilation with fraction of inspired oxygen between 0.21 and 1

Outcome Measures

Primary Outcome Measures

  1. Change in Stroke volume in milliliters [Change from Baseline stroke volume At ICU admission and through study completion An average 6 months]

    Volume of blood in milliliters that is ejected from heart each second and measured By Echocardiography

  2. Change in ejection fraction of heart in percentage [Change from baseline ejection fraction at icu admission and through study completion An Average 6 months]

    percentage of blood that's pumped out of a filled ventricle with each heartbeat And measured by echocardiography

Secondary Outcome Measures

  1. Acute respiratory distress syndrome [From icu admission date to icu discharge date an average of 2 weeks]

    Acute persistent hypoxia with bilateral lung infiltrate due to non cardiac cause

  2. Sepsis [From icu admission date to icu discharge date an average of 2 weeks]

    Systolic blood pressure < 90 Respiratory rate > 22 Heart rate > 100

  3. Stroke [From icu admission date to icu discharge date an average of 2 weeks]

    Cerebrovascular accidents

  4. Mechanical Ventilator free days [From icu admission date to icu discharge date an average of 2 weeks]

    Days without mechanical ventilation

  5. Shock [From icu admission date to icu discharge date an average of 2 weeks]

    Systolic blood pressure < 90 mmHg

  6. Surgery revision [From icu admission date to icu discharge date an average of 2 weeks]

    Surgical re exploration

  7. Vasopressor [From icu admission date to icu discharge date an average of 2 weeks]

    Use of vasopressors as norepinephrine and epinephrine

  8. ICU stay [From icu admission date to icu discharge date an average of 2 weeks]

    Duration of intensive care stay

  9. Hospital stay [From icu admission date to icu discharge date an average of 2 weeks]

    Duration of hospital stay

  10. Mortality [From icu admission date to icu discharge date an average of 2 weeks]

    Death of patient

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adults aged 18 years or older admitted to ICU and expected to receive mechanical ventilation beyond next calendar day
Exclusion Criteria:
  • inclusion in other trial

  • severe acute respiratory distress syndrome at time of admission

  • acute Chronic obstructive airway disease exacerbation

  • pregnancy

  • Carbon monoxide poisoning

  • Guillain Barre syndrome

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aswan university hospital Aswan Egypt

Sponsors and Collaborators

  • Aswan University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Sayed Mohamed Tammam, Assistant lecturer, Aswan University Hospital
ClinicalTrials.gov Identifier:
NCT04824703
Other Study ID Numbers:
  • Aswu/460/5/20
First Posted:
Apr 1, 2021
Last Update Posted:
Feb 10, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Ahmed Sayed Mohamed Tammam, Assistant lecturer, Aswan University Hospital

Study Results

No Results Posted as of Feb 10, 2022